Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
184
184 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- PalazestrantOP-1250Phase 32 trials
Olema Oncology, Inc. · Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- RYZ101Phase 32 trials
RayzeBio, Inc. · Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer
- SV-BR-1-GMthe Bria-IMTPhase 32 trials
BriaCell Therapeutics Corporation · Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm
- TOL2506Phase 32 trials
Tolmar Inc. · Breast Cancer
- XZP-3287Phase 32 trials
Xuanzhu Biopharmaceutical Co., Ltd. · Advanced Breast Cancer
- ZN-A-1041ZN-A-1041 Enteric, RO7771950Phase 32 trials
Roche (Genentech) · HER2-positive Breast Cancer, Advanced Solid Tumors
- BGB-43395Phase 31 trial
BeOne Medicines (BeiGene) · HR+/HER2- Breast Cancer
- DalpciclibPhase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Breast Cancer
- DalpiciclibPhase 31 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Breast Cancer
- FDA018-ADCPhase 31 trial
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Triple Negative Breast Cancer
- Fixed of PertuzumabPhase 31 trial
Roche (Genentech) · Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer
- GB491Phase 31 trial
Genor Biopharma Co., Ltd. · Breast Cancer
- GLSI-100Phase 31 trial
Greenwich LifeSciences, Inc. · Breast Cancer
- GQ1005Phase 31 trial
GeneQuantum Healthcare (Suzhou) Co., Ltd. · HER2-positive Breast Cancer
- Hemay022Phase 31 trial
Tianjin Hemay Pharmaceutical Co., Ltd · Breast Cancer
- HLX11Phase 31 trial
Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
- HS627Phase 31 trial
BioRay Pharmaceutical Co., Ltd. · Breast Cancer
- HX22Phase 31 trial
Shanghai Henlius Biotech · HER2 + Breast Cancer
- JYP0035Phase 31 trial
Chengdu JOYO pharma Co., Ltd. · Breast Cancer
- NTQ1062Phase 31 trial
Nanjing Chia-tai Tianqing Pharmaceutical · HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer
- RPH-051Phase 31 trial
R-Pharm · Locally Advanced Breast Cancer, Metastatic Breast Cancer
- SHR6390Phase 31 trial
Jiangsu HengRui Medicine Co., Ltd. · Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast Cancer
- SIM0270Phase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Locally Advanced or Metastatic Breast Cancer
- SRG-514Phase 31 trial
SURGE Therapeutics · TNBC - Triple-Negative Breast Cancer
- ZovegalisibPhase 31 trial
Relay Therapeutics, Inc. · PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor
- SI-B003Phase 210 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
- RO7247669Tobemstomig, RG6139Phase 26 trials
Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer
- Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials
Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)
- EvorpaceptALX148Phase 25 trials
ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic
- PalacaparibAZD9574Phase 25 trials
AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer
- Zelenectide pevedotinBT8009Phase 25 trials
BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors
- IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials
Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma
- MHB039APhase 24 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor, Advanced Breast Cancer, Advanced Lung Cancer
- ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials
MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer
- AK146D1Phase 23 trials
Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)
- AlisertibPB-8237, MLN8237Phase 23 trials
Puma Biotechnology, Inc. · Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
- BT5528nuzefatide pevedotinPhase 23 trials
BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer
- GV20-0251Phase 23 trials
GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum
- HRS-2189Phase 23 trials
Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Breast Cancer, Prostate Cancer
- MHB036CPhase 23 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Breast Cancer, Advanced Malignant Solid Tumor, Advanced Lung Cancer
- PelareorepPhase 23 trials
Oncolytics Biotech · Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic
- SamuraciclibICEC0942, CT7001Phase 23 trials
Carrick Therapeutics Limited · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer
- [177Lu]Lu-NeoBLutetium NeoB, [177Lu]-NeoBPhase 22 trials
Novartis · Breast Cancer, Neoplasms
- [68Ga]Ga-NeoBGallium NeoB, [68Ga]-NeoBPhase 22 trials
Novartis · Breast Cancer, Neoplasms
- AK138D1Phase 22 trials
Akeso · Non-Small Cell Lung Cancer, Breast Cancer
- AVZO-021Phase 22 trials
Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor
- B1962Phase 22 trials
Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers
- BLEX 404 LiquidPhase 22 trials
BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer
- BreakVaxPhase 22 trials
BreakBio Corp · Triple-Negative Breast Cancer (TNBC), Glioblastoma (GBM)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.